Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Resistant Hypertension
NCT04478500Phase 3Unknown
- Sponsor
- Royal Perth Hospital
- Start
- Jul 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in resistant hypertension (RH), sponsored by Royal Perth Hospital. Status: unknown.
02
Drugs
minocycline
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT04478500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478500.